BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36868843)

  • 1. COVID-19 infection elicits textbook immune response.
    Krátká Z; Fürst T; Fejt V
    Cas Lek Cesk; 2023; 161(7-8):325-328. PubMed ID: 36868843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital anomalies in children born in the Czech Republic in 1994-2015.
    Šípek A; Gregor V; Šípek A; Klaschka J; Malý M; Jírová J
    Cas Lek Cesk; 2019; 158(1):9-14. PubMed ID: 31046386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromonitoring of recurrent laryngeal nerves in thyroid surgery comparative study of visualisation and electrophysiology methods.
    Astl J; Holý R; Rotnágl J; Hložek J
    Rozhl Chir; 2021; 100(3):113-117. PubMed ID: 33910356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue in the treatment of androgenic alopecia.
    Stefanis AJ
    Cas Lek Cesk; 2023; 162(1):9-12. PubMed ID: 37185037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21-Associated ncRNA DNA Damage-Activated Expression in Bladder Cancer.
    Abdolmaleki F; Ghafouri-Fard S; Taheri M; Omrani DM
    Klin Onkol; 2019; 32(4):277-280. PubMed ID: 31426643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual homicide attempt: A case report and a short review of the literature.
    Maria KV; Maria M; Eirini G; Maria A; Polychronis V; Athanasios D; Pavlos P
    Soud Lek; 2019; 64(2):14-19. PubMed ID: 31726837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
    Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
    J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal and weekly fluctuations in alcohol use in the Czech Republic.
    Barták M; Vacek J; Petruželka B; Nejedlá M; Rogalewicz V
    Cas Lek Cesk; 2023; 162(2-3):48-51. PubMed ID: 37474286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.
    Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA
    Front Immunol; 2021; 12():693462. PubMed ID: 34691016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
    Vesper N; Ortiz Y; Bartels-Burgahn F; Yang J; de la Rosa K; Tenbusch M; Schulz S; Finzel S; Jäck HM; Eibel H; Voll RE; Reth M
    Front Immunol; 2021; 12():730766. PubMed ID: 34630410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
    Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
    Front Immunol; 2021; 12():793191. PubMed ID: 34975897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).
    Ruetalo N; Flehmig B; Schindler M; Pridzun L; Haage A; Reichenbächer M; Kirchner T; Kirchner T; Klingel K; Ranke MB; Normann A
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
    Epsi NJ; Richard SA; Lindholm DA; Mende K; Ganesan A; Huprikar N; Lalani T; Fries AC; Maves RC; Colombo RE; Larson DT; Smith A; Chi SW; Maldonado CJ; Ewers EC; Jones MU; Berjohn CM; Libraty DH; Edwards MS; English C; Rozman JS; Mody RM; Colombo CJ; Samuels EC; Nwachukwu P; Tso MS; Scher AI; Byrne C; Rusiecki J; Simons MP; Tribble D; Broder CC; Agan BK; Burgess TH; Laing ED; Pollett SD;
    Clin Infect Dis; 2023 Feb; 76(3):e439-e449. PubMed ID: 35608504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.
    Beppu H; Ogawa T; Ishikane M; Kawanishi T; Fukuda T; Sato L; Matsunaga A; Maeda K; Katagiri D; Ishizaka Y; Mitsuya H; Ohmagari N; Yasui F; Kohara M; Kikuchi K; Wakai S
    CEN Case Rep; 2022 Nov; 11(4):422-427. PubMed ID: 35266095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies.
    Svačina MKR; Meißner A; Schweitzer F; Ladwig A; Sprenger-Svačina A; Klein I; Wüstenberg H; Kohle F; Schneider C; Grether NB; Wunderlich G; Fink GR; Klein F; Di Cristanziano V; Lehmann HC
    Eur J Neurol; 2022 Nov; 29(11):3380-3388. PubMed ID: 35842740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.